SYNTHESIS SRL
- Company typePrivate
- Founded2015
- HeadquartersGUIDONIA, ROMA, Italy
- Headcount1–10
- GTM typeB2B
- OfferingServices
SYNTHESIS SRL firmographics
Firmographics- Name
- SYNTHESIS SRL
- Legal name
- Synthesis S.r.l.
- Website
- https://synthesis-pharma.it
- Company type
- Private
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Ownership category
- akta.pro rank
SYNTHESIS SRL industry classification
Industry- Product category
- Pharmaceutical Contract Manufacturing
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254)
- SIC
- Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Contract Development & Manufacturing for Generics (CDMO/CMO) (HLAIABAI)
- akta.pro secondary industries
- Generic Finished Dosage Form (FDF) Manufacturing (HLAIABAH), GMP Quality, Validation & Regulatory Support (GMP/CSV/Qualification) (HLAGAGAL)
Keywords
Where SYNTHESIS SRL is headquartered
LocationHeadquarters
- HQ city
- GUIDONIA, ROMA
- HQ country
- Italy
- HQ region
- Europe
Offices1 record
Markets served
SYNTHESIS SRL business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Supply Chain, Technology or R&D, Marketing or Sales
Revenue model
- Contract Pharmaceutical Manufacturing: Third-party pharmaceutical contract manufacturing services for sterile liquids and non-sterilizable products under GMP standards. Revenue is generated through service contracts with pharmaceutical companies requiring specialized manufacturing capabilities.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels1 record
SYNTHESIS SRL product offering
Product offeringCore offering
Synthesis SRL operates an AIFA-authorized pharmaceutical production facility in Guidonia Montecelio (Rome), Italy, providing contract manufacturing services for sterile liquids and non-sterilizable products under GMP (Good Manufacturing Practice) standards. The company produces pharmaceutical dosage forms on behalf of third-party pharmaceutical companies that lack in-house GMP-certified manufacturing capabilities.
Product overview
Synthesis SRL operates a single core pharmaceutical contract manufacturing service, producing sterile liquids and non-sterilizable pharmaceutical products for third parties under GMP standards, authorized by AIFA. The company functions as a single-product service offering rather than a multi-product platform.
Differentiator
Problem solved
Functional benefit
Products and services
- Synthesis Pharma – Officina di Produzione Farmaceutica AIFA-authorized contract pharmaceutical manufacturing service specializing in the production of sterile liquids and non-sterilizable products under GMP standards for pharmaceutical company clients that require third-party GMP-compliant manufacturing capabilities.
Companies that use SYNTHESIS SRL
Customer profileSegments1 record
Ideal customer profiles1 record
SYNTHESIS SRL technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
SYNTHESIS SRL partnerships and signals
Strategic signalRecent moves2 records
SYNTHESIS SRL competitors and assessment
Company assessmentBroad incumbents
- Recipharm: One of Europe's largest CDMOs offering sterile fill-finish, oral liquids, and a broad range of pharmaceutical manufacturing services. Comparable as a larger incumbent in the same European CDMO space.
- Catalent: Global CDMO with extensive sterile injectable and liquid manufacturing capabilities. Comparable as a broad incumbent offering overlapping contract manufacturing services for sterile pharmaceutical products.
- Patheon (Thermo Fisher Scientific): Global CDMO offering sterile liquid and aseptic fill-finish services under the Thermo Fisher umbrella. Comparable as a broad incumbent with overlapping pharmaceutical contract manufacturing capabilities.
Direct peers
- CordenPharma: European-headquartered CDMO offering sterile liquid and injectable manufacturing services to pharmaceutical clients. Directly comparable as a contract manufacturer serving pharma customers with GMP-certified aseptic capabilities.
- Fareva: French pharmaceutical CDMO providing sterile and non-sterile contract manufacturing, including liquid dosage forms. Comparable as a multi-site European CMO serving branded and generic pharmaceutical companies.
- Olon Group: Italian-headquartered pharmaceutical CDMO providing API and finished dosage manufacturing including sterile forms. Comparable as a domestic Italian CDMO serving pharmaceutical clients under GMP.
Regional players
- ACS DOBFAR: Italian pharmaceutical manufacturer with sterile injectable and beta-lactam capabilities. Comparable as a regional Italian pharmaceutical manufacturer in adjacent sterile and injectable categories.
Others
- Bouchara-Recordati: French/Italian-affiliated pharmaceutical manufacturer producing sterile injectable and liquid formulations. Comparable as an adjacent pharmaceutical manufacturer serving similar therapeutic categories under European GMP.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat2 records
Key risks6 records
Key highlights5 records
Customer concentration
SYNTHESIS SRL social profiles
Digital presenceSYNTHESIS SRL compliance and trust
Trust signalCompliance1 record
SYNTHESIS SRL financial estimates
Financial estimateRevenue estimate
Valuation estimate
SYNTHESIS SRL leadership team
Management profileNumber of profiles
SYNTHESIS SRL funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
SYNTHESIS SRL M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about SYNTHESIS SRL
What does SYNTHESIS SRL do?
Synthesis SRL operates an AIFA-authorized pharmaceutical production facility in Guidonia Montecelio (Rome), Italy, providing contract manufacturing services for sterile liquids and non-sterilizable products under GMP (Good Manufacturing Practice) standards. The company produces pharmaceutical dosage forms on behalf of third-party pharmaceutical companies that lack in-house GMP-certified manufacturing capabilities.
Is SYNTHESIS SRL a public or private company?
SYNTHESIS SRL is a private company. It is classified as unknown and is currently operating.
When was SYNTHESIS SRL founded?
SYNTHESIS SRL was founded in 2015. It employs 1 to 10 people.
Where is SYNTHESIS SRL based?
SYNTHESIS SRL is headquartered in GUIDONIA, ROMA, Italy, in the Europe region.
How does SYNTHESIS SRL make money?
One revenue line is on record: contract Pharmaceutical Manufacturing.
Who are SYNTHESIS SRL's main competitors?
Broad incumbents on record are Recipharm, Catalent and Patheon (Thermo Fisher Scientific). Direct peers are CordenPharma, Fareva and Olon Group. ACS DOBFAR is listed as a regional player. Bouchara-Recordati is listed as an others.
Does SYNTHESIS SRL have an API?
No public API is recorded for SYNTHESIS SRL.
What industry is SYNTHESIS SRL in?
SYNTHESIS SRL's product category is Pharmaceutical Contract Manufacturing. Its primary akta.pro industry code is HLAIABAI, Contract Development & Manufacturing for Generics (CDMO/CMO), with a secondary code of HLAIABAH, Generic Finished Dosage Form (FDF) Manufacturing. Its NAICS code is 325412 and its SIC code is 2834.